Pub Date : 2026-03-17DOI: 10.1016/j.surg.2026.110136
Hallbera Gudmundsdottir, Fabricio J Hernandez-Delima, Bryan C McDowell, Patrick Starlinger, Cornelius A Thiels, Susanne G Warner, Thorvardur R Halfdanarson, Patrick J Navin, Annie T Packard, Sean P Cleary
Background: Regional lymph node involvement impacts prognosis for patients with pancreatic neuroendocrine tumors and may influence management decisions for small tumors. Conventional cross-sectional imaging modalities have low sensitivity in detecting regional lymph node metastases, but the diagnostic performance of somatostatin receptor positron emission tomography for this is unknown.
Methods: Patients with pancreatic neuroendocrine tumors who underwent preoperative gallium 68 DOTATATE positron emission tomography followed by resection with lymphadenectomy from 2017 to 2022 were reviewed. Preoperative gallium 68 DOTATATE positron emission tomography was retrospectively reviewed by radiologists. The presence of suspicious regional lymph nodes was correlated with pathologic reports to determine diagnostic accuracy.
Results: Among 130 patients who met inclusion criteria, DOTATATE positron emission tomography detected suspicious lymph nodes in 24%, whereas pathologic evaluation demonstrated lymph node involvement in 42%. Overall, sensitivity was 46% and specificity was 92%, with a positive predictive value of 81% and negative predictive value of 29%. Among patients with lymph node involvement confirmed on pathologic review, 92% of patients with true-positive results had a Krenning score of 4 compared with 59% of patients with false-negative results (P = .013), and 58% of patients with true-positive results had lymph nodes >1 cm on preoperative cross-sectional imaging compared with 8.7% of patients with false-negative results (P < .001).
Conclusion: Gallium 68 DOTATATE positron emission tomography has limited sensitivity but high specificity for preoperative diagnosis of regional pancreatic neuroendocrine tumor lymph node metastases. Detection rate improves with higher Krenning score and larger lymph node size. This study has important implications for preoperative planning, particularly for patients with small tumors who may be candidates for either observation or resection.
{"title":"Diagnostic performance of somatostatin receptor positron emission tomography in preoperative evaluation of pancreatic neuroendocrine tumor lymph node metastases.","authors":"Hallbera Gudmundsdottir, Fabricio J Hernandez-Delima, Bryan C McDowell, Patrick Starlinger, Cornelius A Thiels, Susanne G Warner, Thorvardur R Halfdanarson, Patrick J Navin, Annie T Packard, Sean P Cleary","doi":"10.1016/j.surg.2026.110136","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110136","url":null,"abstract":"<p><strong>Background: </strong>Regional lymph node involvement impacts prognosis for patients with pancreatic neuroendocrine tumors and may influence management decisions for small tumors. Conventional cross-sectional imaging modalities have low sensitivity in detecting regional lymph node metastases, but the diagnostic performance of somatostatin receptor positron emission tomography for this is unknown.</p><p><strong>Methods: </strong>Patients with pancreatic neuroendocrine tumors who underwent preoperative gallium 68 DOTATATE positron emission tomography followed by resection with lymphadenectomy from 2017 to 2022 were reviewed. Preoperative gallium 68 DOTATATE positron emission tomography was retrospectively reviewed by radiologists. The presence of suspicious regional lymph nodes was correlated with pathologic reports to determine diagnostic accuracy.</p><p><strong>Results: </strong>Among 130 patients who met inclusion criteria, DOTATATE positron emission tomography detected suspicious lymph nodes in 24%, whereas pathologic evaluation demonstrated lymph node involvement in 42%. Overall, sensitivity was 46% and specificity was 92%, with a positive predictive value of 81% and negative predictive value of 29%. Among patients with lymph node involvement confirmed on pathologic review, 92% of patients with true-positive results had a Krenning score of 4 compared with 59% of patients with false-negative results (P = .013), and 58% of patients with true-positive results had lymph nodes >1 cm on preoperative cross-sectional imaging compared with 8.7% of patients with false-negative results (P < .001).</p><p><strong>Conclusion: </strong>Gallium 68 DOTATATE positron emission tomography has limited sensitivity but high specificity for preoperative diagnosis of regional pancreatic neuroendocrine tumor lymph node metastases. Detection rate improves with higher Krenning score and larger lymph node size. This study has important implications for preoperative planning, particularly for patients with small tumors who may be candidates for either observation or resection.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"194 ","pages":"110136"},"PeriodicalIF":2.7,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147481715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-16DOI: 10.1016/j.surg.2026.110148
Mengjing Xiao, Peirong Zhang, Xiaofang Zou, Hongming Yang
Background: The early progression of burn wounds poses a significant clinical challenge. Although inflammatory cell death is thought to be involved, the role of the newly discovered integrated cell death pathway PANoptosis in burn injuries has not yet been studied. Baicalin is a natural compound with anti-inflammatory properties and has therapeutic potential, but its impact on burn progression and PANoptosis is unknown.
Methods: A rat comb burn model was established. PANoptosis activation was assessed in the zone of stasis via Western blot, immunohistochemistry, and immunofluorescence for key markers (ZBP1, pMLKL, cleaved GSDMD, cleaved caspase-3, and ASC). In the intervention study, baicalin (100 mg/kg) or vehicle was administered for 7 days. PANoptosis markers, inflammatory cytokines (interleukin 1β, interleukin 6, interleukin 18, tumor necrosis factor α), myeloperoxidase activity, and histopathologic wound progression were evaluated.
Results: Burn injury induced time-dependent PANoptosis activation, characterized by coordinated upregulation of ZBP1, pMLKL, cleaved GSDMD, and cleaved caspase-3. Immunofluorescence confirmed PANoptosome assembly via ASC/cleaved caspase-3 colocalization. Baicalin treatment significantly suppressed all 3 PANoptosis executers, disrupted complex formation, reduced proinflammatory cytokines, and myeloperoxidase activity. Importantly, baicalin treatment significantly reduced the progression of burn wounds at day 7, as evidenced by diminished tissue necrosis and improved tissue architecture.
Conclusion: Our study identifies PANoptosis as a novel pathogenic mechanism contributing to burn wound progression. We further demonstrate that baicalin is an effective therapeutic agent that alleviates tissue damage possibly by inhibiting the PANoptosis pathway and its associated inflammatory cascade. These findings provide a new mechanistic understanding and highlight the therapeutic potential of baicalin for preventing burn wound deepening.
{"title":"Baicalin attenuates burn wound progression by suppressing PANoptosis in the zone of stasis.","authors":"Mengjing Xiao, Peirong Zhang, Xiaofang Zou, Hongming Yang","doi":"10.1016/j.surg.2026.110148","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110148","url":null,"abstract":"<p><strong>Background: </strong>The early progression of burn wounds poses a significant clinical challenge. Although inflammatory cell death is thought to be involved, the role of the newly discovered integrated cell death pathway PANoptosis in burn injuries has not yet been studied. Baicalin is a natural compound with anti-inflammatory properties and has therapeutic potential, but its impact on burn progression and PANoptosis is unknown.</p><p><strong>Methods: </strong>A rat comb burn model was established. PANoptosis activation was assessed in the zone of stasis via Western blot, immunohistochemistry, and immunofluorescence for key markers (ZBP1, pMLKL, cleaved GSDMD, cleaved caspase-3, and ASC). In the intervention study, baicalin (100 mg/kg) or vehicle was administered for 7 days. PANoptosis markers, inflammatory cytokines (interleukin 1β, interleukin 6, interleukin 18, tumor necrosis factor α), myeloperoxidase activity, and histopathologic wound progression were evaluated.</p><p><strong>Results: </strong>Burn injury induced time-dependent PANoptosis activation, characterized by coordinated upregulation of ZBP1, pMLKL, cleaved GSDMD, and cleaved caspase-3. Immunofluorescence confirmed PANoptosome assembly via ASC/cleaved caspase-3 colocalization. Baicalin treatment significantly suppressed all 3 PANoptosis executers, disrupted complex formation, reduced proinflammatory cytokines, and myeloperoxidase activity. Importantly, baicalin treatment significantly reduced the progression of burn wounds at day 7, as evidenced by diminished tissue necrosis and improved tissue architecture.</p><p><strong>Conclusion: </strong>Our study identifies PANoptosis as a novel pathogenic mechanism contributing to burn wound progression. We further demonstrate that baicalin is an effective therapeutic agent that alleviates tissue damage possibly by inhibiting the PANoptosis pathway and its associated inflammatory cascade. These findings provide a new mechanistic understanding and highlight the therapeutic potential of baicalin for preventing burn wound deepening.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"194 ","pages":"110148"},"PeriodicalIF":2.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147475175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-16DOI: 10.1016/j.surg.2026.110119
Patrick Strzempek, Pauline Aeschbacher, Elad Boaz, Brett Weiss, Sameh Hany Emile, Justin Dourado, Peter Rogers, Zoe Garoufalia, Samuel Szomstein, Emanuele Lo Menzo, Raul J Rosenthal
Background: Symptomatic recurrence after hiatal hernia repair poses several challenges, particularly as surgical options are limited. The use of mesh during hiatal hernia repair is controversial, as it is associated with long-term complications and a higher morbidity rate in case of redo surgery. Nevertheless, proponents of this technique argue that its use might reduce the risk of recurrence.
Methods: A retrospective analysis of hiatal hernia repair from 2011 to 2022 performed at our clinic was conducted. All hiatus defects were closed using barbed nonresorbable sutures without mesh. Univariate and multivariate logistic regression analyzed patient and operative characteristics for associations with early symptomatic recurrence in patients with ≥12-month follow-up. Early symptomatic recurrence was defined as redo surgery within 1-year post-primary repair. Kaplan-Meier estimator and log-rank test assessed cumulative recurrence rate.
Results: Of 1,226 patients with hiatal hernia repair, 74.1% (n = 908) were female, median age was 65 years (interquartile range 54, 72), and median body mass index was 28 kg/m2 (interquartile range 25, 33). Of repairs, 99.6% (n = 1,221) were laparoscopic and 14.4% (n = 177) were redo surgery, of which 43 had a previous mesh placement. Reoperation and mortality rates at 30 days were 2.6% (n = 32) and 0.1% (n = 1), respectively. Median follow-up was 12 months (interquartile range 1, 44). Symptomatic recurrences requiring reoperation were observed in 47 (3.8%) cases. In the univariate and multivariate logistic regression of 610 patients with ≥12-month follow-up, 2.5% (n = 15) experienced symptomatic recurrences. Open repair (odds ratio 5.37, P = .008) and redo surgery with previous mesh (odds ratio 7.69, P = .013) were independent risk factors for early recurrence with an area under the curve of 0.64. The cumulative recurrence rate at 1 year was significantly impacted by mesh use in previous repair (7.3%) compared with no mesh (2.9%) or no previous repair (1.4%) (P = .024).
Conclusion: Barbed nonresorbable suture closure during hiatal hernia repair is safe and effective in the short term. Open repair and redo surgery with previous mesh placement were associated with higher 1-year recurrence rates, underscoring the need for careful consideration in surgical planning.
{"title":"Hiatal hernia repair: A single-institution experience and risk factors associated with early symptomatic recurrence.","authors":"Patrick Strzempek, Pauline Aeschbacher, Elad Boaz, Brett Weiss, Sameh Hany Emile, Justin Dourado, Peter Rogers, Zoe Garoufalia, Samuel Szomstein, Emanuele Lo Menzo, Raul J Rosenthal","doi":"10.1016/j.surg.2026.110119","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110119","url":null,"abstract":"<p><strong>Background: </strong>Symptomatic recurrence after hiatal hernia repair poses several challenges, particularly as surgical options are limited. The use of mesh during hiatal hernia repair is controversial, as it is associated with long-term complications and a higher morbidity rate in case of redo surgery. Nevertheless, proponents of this technique argue that its use might reduce the risk of recurrence.</p><p><strong>Methods: </strong>A retrospective analysis of hiatal hernia repair from 2011 to 2022 performed at our clinic was conducted. All hiatus defects were closed using barbed nonresorbable sutures without mesh. Univariate and multivariate logistic regression analyzed patient and operative characteristics for associations with early symptomatic recurrence in patients with ≥12-month follow-up. Early symptomatic recurrence was defined as redo surgery within 1-year post-primary repair. Kaplan-Meier estimator and log-rank test assessed cumulative recurrence rate.</p><p><strong>Results: </strong>Of 1,226 patients with hiatal hernia repair, 74.1% (n = 908) were female, median age was 65 years (interquartile range 54, 72), and median body mass index was 28 kg/m<sup>2</sup> (interquartile range 25, 33). Of repairs, 99.6% (n = 1,221) were laparoscopic and 14.4% (n = 177) were redo surgery, of which 43 had a previous mesh placement. Reoperation and mortality rates at 30 days were 2.6% (n = 32) and 0.1% (n = 1), respectively. Median follow-up was 12 months (interquartile range 1, 44). Symptomatic recurrences requiring reoperation were observed in 47 (3.8%) cases. In the univariate and multivariate logistic regression of 610 patients with ≥12-month follow-up, 2.5% (n = 15) experienced symptomatic recurrences. Open repair (odds ratio 5.37, P = .008) and redo surgery with previous mesh (odds ratio 7.69, P = .013) were independent risk factors for early recurrence with an area under the curve of 0.64. The cumulative recurrence rate at 1 year was significantly impacted by mesh use in previous repair (7.3%) compared with no mesh (2.9%) or no previous repair (1.4%) (P = .024).</p><p><strong>Conclusion: </strong>Barbed nonresorbable suture closure during hiatal hernia repair is safe and effective in the short term. Open repair and redo surgery with previous mesh placement were associated with higher 1-year recurrence rates, underscoring the need for careful consideration in surgical planning.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"193 ","pages":"110119"},"PeriodicalIF":2.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147481692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-16DOI: 10.1016/j.surg.2026.110149
Galinos Barmparas, Aleeque Marselian, Falisha Kanji, Harshini Ravi, Bruce L Gewertz, Tara Cohen
Background: High-fidelity trauma simulation offers a unique opportunity to improve teamwork, communication, and crisis management in the operating room. Beyond technical skill acquisition, such simulations may foster interprofessional respect, self-reflection, and systems-level quality improvement awareness.
Methods: A post-simulation survey was completed by 90 participants following 2 high-fidelity trauma surgery scenarios conducted in a simulated operating room at an academic level 1 trauma center. Respondents included surgeons, surgical residents, anesthesiologists, circulating nurses, and scrub technicians from 8 institutions. Confidence in communication, teamwork, and role appreciation were measured using 5-point Likert scales and analyzed with paired-samples t tests and repeated-measures analysis of variance. Qualitative and quantitative items assessed perceived impact on communication practices and opportunities for process improvement.
Results: Confidence in communication improved from 3.67 ± 0.97 at baseline to 4.15 ± 0.81 after scenario 1 and 4.51 ± 0.61 after scenario 2 (P < .001 for all paired comparisons). Eighty-eight percent reported that participation in the simulation influenced how they would communicate in the operating room in the future, with the most common intended changes including enhanced name recognition (70%), closed-loop communication (70%), active listening (67%), and more frequent updates on patient status (47%). Participants emphasized the value of simulation as a quality-improvement tool, citing increased awareness of latent system issues, and the importance of interdisciplinary readiness. Perceived role importance increased most for circulating nurses (59%), anesthesiologists (49%), and scrub technicians (48%).
Conclusion: High-fidelity trauma simulation improved communication, strengthened teamwork, and promoted a culture of reflection and quality improvement across operating room disciplines. These findings support routine integration of immersive simulation into surgical and interprofessional training.
{"title":"Simulation as a catalyst for surgical teamwork: Insights from a high-fidelity trauma training experience.","authors":"Galinos Barmparas, Aleeque Marselian, Falisha Kanji, Harshini Ravi, Bruce L Gewertz, Tara Cohen","doi":"10.1016/j.surg.2026.110149","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110149","url":null,"abstract":"<p><strong>Background: </strong>High-fidelity trauma simulation offers a unique opportunity to improve teamwork, communication, and crisis management in the operating room. Beyond technical skill acquisition, such simulations may foster interprofessional respect, self-reflection, and systems-level quality improvement awareness.</p><p><strong>Methods: </strong>A post-simulation survey was completed by 90 participants following 2 high-fidelity trauma surgery scenarios conducted in a simulated operating room at an academic level 1 trauma center. Respondents included surgeons, surgical residents, anesthesiologists, circulating nurses, and scrub technicians from 8 institutions. Confidence in communication, teamwork, and role appreciation were measured using 5-point Likert scales and analyzed with paired-samples t tests and repeated-measures analysis of variance. Qualitative and quantitative items assessed perceived impact on communication practices and opportunities for process improvement.</p><p><strong>Results: </strong>Confidence in communication improved from 3.67 ± 0.97 at baseline to 4.15 ± 0.81 after scenario 1 and 4.51 ± 0.61 after scenario 2 (P < .001 for all paired comparisons). Eighty-eight percent reported that participation in the simulation influenced how they would communicate in the operating room in the future, with the most common intended changes including enhanced name recognition (70%), closed-loop communication (70%), active listening (67%), and more frequent updates on patient status (47%). Participants emphasized the value of simulation as a quality-improvement tool, citing increased awareness of latent system issues, and the importance of interdisciplinary readiness. Perceived role importance increased most for circulating nurses (59%), anesthesiologists (49%), and scrub technicians (48%).</p><p><strong>Conclusion: </strong>High-fidelity trauma simulation improved communication, strengthened teamwork, and promoted a culture of reflection and quality improvement across operating room disciplines. These findings support routine integration of immersive simulation into surgical and interprofessional training.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"194 ","pages":"110149"},"PeriodicalIF":2.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147475215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-16DOI: 10.1016/j.surg.2026.110141
Michael A Jacobs, Paula K Shireman, Jonathan C Silverstein, Daniel E Hall
{"title":"Do machine learning models add value in assessing operative stress?","authors":"Michael A Jacobs, Paula K Shireman, Jonathan C Silverstein, Daniel E Hall","doi":"10.1016/j.surg.2026.110141","DOIUrl":"10.1016/j.surg.2026.110141","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"194 ","pages":"110141"},"PeriodicalIF":2.7,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147475206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06DOI: 10.1016/j.surg.2026.110124
Michael G House
{"title":"Commentary on \"Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomised controlled trials\".","authors":"Michael G House","doi":"10.1016/j.surg.2026.110124","DOIUrl":"https://doi.org/10.1016/j.surg.2026.110124","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"110124"},"PeriodicalIF":2.7,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147373187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Phase 3 clinical trial data have suggested that perioperative administration of corticosteroids may improve postoperative outcomes by suppressing inflammatory and immune responses associated with surgery. We sought to investigate the real-world effectiveness of corticosteroid administration to improve postoperative outcomes among patients undergoing hepatopancreatobiliary surgery.
Methods
Patients who underwent hepatopancreatobiliary surgery (excluding simple cholecystectomy) between 2016 and 2024 were identified using the Epic Cosmos database. The primary exposure was the administration of a single shot of corticosteroids (methylprednisolone or hydrocortisone) on the day of surgery. Stabilized inverse probability of treatment weighting was used to examine the association between administration of corticosteroids and postoperative outcomes (ie, complications, length of stay, and 90-day mortality).
Results
Among 125,269 patients, a majority underwent pancreatic surgery (n = 65,663, 52.4%) for a nonmalignant indication (n = 79,145, 63.2%). Overall, 2.2% of patients (n = 2,782) were administered corticosteroids on the day of surgery. Patients who did versus did not receive corticosteroids were more likely to be younger (61.9 years [standard deviation ±14.7 years] vs 63.8 years [standard deviation ±14.8 years]), have a higher Charlson Comorbidity Index (>2) (79.5% vs 72.2%), and undergo hepatic surgery (42.7% vs 31.0%) via an open surgical approach (93.4% vs 86.5%) for a nonmalignant indication (72.9% vs 63.0%) (all P < .05). On inverse probability of treatment weighting analysis after adjusting for relevant clinicodemographic factors, administration of corticosteroids was associated with higher odds of postoperative complications (odds ratio: 2.16 [95% confidence interval: 1.93–2.42]), extended length of stay (>75th percentile) (odds ratio: 1.56 [95% confidence interval: 1.40–1.73]), and 90-day mortality (odds ratio: 1.26 [95% confidence interval: 1.11–1.41]) (all P < .001). On subgroup analyses, the administration of corticosteroids did not impact the incidence of bile leak among patients undergoing hepatobiliary surgery (odds ratio: 1.15 [95% confidence interval: 0.92–1.43]), nor did it affect the incidence of pancreatic fistula among patients undergoing pancreatic surgery (odds ratio: 1.11 [95% confidence interval: 0.83–1.47]) (both P > .05).
Conclusion
Based on real-world electronic health record data, administration of corticosteroids was not associated with improved outcomes after a hepatopancreatobiliary surgical procedure. Rather, use of same-day corticosteroids had a detrimental effect on postoperative outcomes, suggesting that steroids should not be routinely used in the perioperative hepatopancreatobiliary setting.
{"title":"Impact of corticosteroids on postoperative outcomes after hepatopancreatobiliary surgery","authors":"Abdullah Altaf MD, Selamawit Woldesenbet PhD, Kathleen Tong BA, Mujtaba Khalil MD, Miho Akabane MD, Zayed Rashid MD, Shahzaib Zindani MD, Azza Sarfraz MBBS, Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FSSO, FRACS (Hon)","doi":"10.1016/j.surg.2025.109916","DOIUrl":"10.1016/j.surg.2025.109916","url":null,"abstract":"<div><h3>Background</h3><div>Phase 3 clinical trial data have suggested that perioperative administration of corticosteroids may improve postoperative outcomes by suppressing inflammatory and immune responses associated with surgery. We sought to investigate the real-world effectiveness of corticosteroid administration to improve postoperative outcomes among patients undergoing hepatopancreatobiliary surgery.</div></div><div><h3>Methods</h3><div>Patients who underwent hepatopancreatobiliary surgery (excluding simple cholecystectomy) between 2016 and 2024 were identified using the Epic Cosmos database. The primary exposure was the administration of a single shot of corticosteroids (methylprednisolone or hydrocortisone) on the day of surgery. Stabilized inverse probability of treatment weighting was used to examine the association between administration of corticosteroids and postoperative outcomes (ie, complications, length of stay, and 90-day mortality).</div></div><div><h3>Results</h3><div>Among 125,269 patients, a majority underwent pancreatic surgery (<em>n</em> = 65,663, 52.4%) for a nonmalignant indication (<em>n</em> = 79,145, 63.2%). Overall, 2.2% of patients (<em>n</em> = 2,782) were administered corticosteroids on the day of surgery. Patients who did versus did not receive corticosteroids were more likely to be younger (61.9 years [standard deviation ±14.7 years] vs 63.8 years [standard deviation ±14.8 years]), have a higher Charlson Comorbidity Index (>2) (79.5% vs 72.2%), and undergo hepatic surgery (42.7% vs 31.0%) via an open surgical approach (93.4% vs 86.5%) for a nonmalignant indication (72.9% vs 63.0%) (all <em>P</em> < .05). On inverse probability of treatment weighting analysis after adjusting for relevant clinicodemographic factors, administration of corticosteroids was associated with higher odds of postoperative complications (odds ratio: 2.16 [95% confidence interval: 1.93–2.42]), extended length of stay (>75th percentile) (odds ratio: 1.56 [95% confidence interval: 1.40–1.73]), and 90-day mortality (odds ratio: 1.26 [95% confidence interval: 1.11–1.41]) (all <em>P</em> < .001). On subgroup analyses, the administration of corticosteroids did not impact the incidence of bile leak among patients undergoing hepatobiliary surgery (odds ratio: 1.15 [95% confidence interval: 0.92–1.43]), nor did it affect the incidence of pancreatic fistula among patients undergoing pancreatic surgery (odds ratio: 1.11 [95% confidence interval: 0.83–1.47]) (both <em>P</em> > .05).</div></div><div><h3>Conclusion</h3><div>Based on real-world electronic health record data, administration of corticosteroids was not associated with improved outcomes after a hepatopancreatobiliary surgical procedure. Rather, use of same-day corticosteroids had a detrimental effect on postoperative outcomes, suggesting that steroids should not be routinely used in the perioperative hepatopancreatobiliary setting.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"191 ","pages":"Article 109916"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-12-03DOI: 10.1016/j.surg.2025.109920
Nebojša Oravec MD, Rebecca Lahamm-Andraos MD, FACS, Emily A. Harris MD, FACS, Adrian M. Harvey MD, FRCSC, FACS, Samantha A. Wolfe MD, FRCSC, Caitlin T. Yeo MD, FRCSC
Background
Parathyroid gland identification and preservation during thyroidectomy has historically relied on experienced visual acumen. Indocyanine green fluorescence imaging has demonstrated improvement in parathyroid gland preservation, but it is unclear if the benefit is limited to less-experienced surgeons. The aim of this study was to identify how often discordant parathyroid viability assessments by surgeon visual perception versus indocyanine green fluorescence resulted in changes in management, stratified by surgeon years of experience.
Methods
Patients undergoing thyroid surgery by high-volume endocrine surgeons were recruited. Perception of parathyroid viability was documented before and after intravenous indocyanine green administration. In cases of discordant assessments, management was at the surgeon's discretion. Rates of discordance and change in management were stratified by surgeon experience—“early career” (<5 years independent practice) and “advanced career” (>15 years independent practice). Results were analyzed using the Pearson χ2 test. The primary outcome was the rate of change in management of the parathyroid on the basis of discordant assessments stratified by surgeon years of experience.
Results
Thirty-five patients were included and comprised 81 observations of parathyroid viability, 50 by early career surgeons and 31 by advanced-career surgeons. Early career surgeons had a discordance rate of 26.0% (n = 13/50) versus 19.3% (n = 6/31) for advanced career surgeons (χ2 = 0.17329, P = .6722). Of the 19 discordant observations, 13 (68.4%) resulted in changes in management (early career = 10/13 = 76.9%; advanced career = 3/6 = 50.0%; χ2 = 1.3772, P = .3093).
Conclusion
These results suggest that indocyanine green fluorescence imaging is a useful adjunct to visual perception, regardless of the surgeon's years of experience.
{"title":"A prospective cohort study of intraoperative parathyroid gland management by early and advanced career surgeons based on viability assessment by visual perception and indocyanine green (ICG) fluorescence imaging","authors":"Nebojša Oravec MD, Rebecca Lahamm-Andraos MD, FACS, Emily A. Harris MD, FACS, Adrian M. Harvey MD, FRCSC, FACS, Samantha A. Wolfe MD, FRCSC, Caitlin T. Yeo MD, FRCSC","doi":"10.1016/j.surg.2025.109920","DOIUrl":"10.1016/j.surg.2025.109920","url":null,"abstract":"<div><h3>Background</h3><div>Parathyroid gland identification and preservation during thyroidectomy has historically relied on experienced visual acumen. Indocyanine green fluorescence imaging has demonstrated improvement in parathyroid gland preservation, but it is unclear if the benefit is limited to less-experienced surgeons. The aim of this study was to identify how often discordant parathyroid viability assessments by surgeon visual perception versus indocyanine green fluorescence resulted in changes in management, stratified by surgeon years of experience.</div></div><div><h3>Methods</h3><div>Patients undergoing thyroid surgery by high-volume endocrine surgeons were recruited. Perception of parathyroid viability was documented before and after intravenous indocyanine green administration. In cases of discordant assessments, management was at the surgeon's discretion. Rates of discordance and change in management were stratified by surgeon experience—“early career” (<5 years independent practice) and “advanced career” (>15 years independent practice). Results were analyzed using the Pearson χ<sup>2</sup> test. The primary outcome was the rate of change in management of the parathyroid on the basis of discordant assessments stratified by surgeon years of experience.</div></div><div><h3>Results</h3><div>Thirty-five patients were included and comprised 81 observations of parathyroid viability, 50 by early career surgeons and 31 by advanced-career surgeons. Early career surgeons had a discordance rate of 26.0% (<em>n</em> = 13/50) versus 19.3% (<em>n</em> = 6/31) for advanced career surgeons (χ<sup>2</sup> = 0.17329, <em>P</em> = .6722). Of the 19 discordant observations, 13 (68.4%) resulted in changes in management (early career = 10/13 = 76.9%; advanced career = 3/6 = 50.0%; χ<sup>2</sup> = 1.3772, <em>P</em> = .3093).</div></div><div><h3>Conclusion</h3><div>These results suggest that indocyanine green fluorescence imaging is a useful adjunct to visual perception, regardless of the surgeon's years of experience.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"191 ","pages":"Article 109920"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-01-20DOI: 10.1016/j.surg.2025.109911
Melissa A. Kendall MD, Emily A. Grimsley MD, Rachel L. Wolansky MD, Joseph Sujka MD, Paul C. Kuo MD, MS, MBA
Background
Firearm-related deaths are prevalent in the United States, with the second greatest total recorded in 2022. Data associating handgun policies with firearm-related crude death rates by all intentions and crude suicide rates remain inconclusive. We aimed to identify associations between handgun policies and crude death rates and crude suicide rates over time.
Methods
We queried the Centers for Disease Control and Prevention database for adult crude death rates and crude suicide rates in the United States and the Research and Development Firearm Database to identify state-specific handgun policies. We analyzed data from 2003 to 2022 using 2 mixed-effects models: crude death rates and crude suicide rates. Linear and quadratic interaction terms captured changes in policy effectiveness over time. Robust standard errors accounted for heteroscedasticity, improving estimate reliability.
Results
Safety training requirements reduced crude death rates by 29.0% (P < .01), followed by possession restrictions (12.2%; P < .01), registration requirements (8.9%; P < .05), and tracing requirements (6.1%; P < .05). Permit requirements reduced crude suicide rates by 15.9% (P < .05), followed by extreme risk protection orders (6.7%; P < .001), untraceable firearms restrictions 5.9%; P < .05), tracing requirements (4.3%; P < .05), and trafficking policies (4.2%; P < .05). Preemption of local policies increased crude suicide rates by 9.8% (P < .01). The effect of tracing requirements increased from 2003–2022 for both crude death rates (6.1% to 30.6%; P < .01) and crude suicide rates (4.3% to 22.5%; P < .05). The effect of preemption of select local policies initially weakened from 2003–2012, (+12.2% to +9.7%), then strengthened to +15.3% in 2022 (P < .01).
Conclusion
Safety training, possession requirements, handgun registration, and tracing policies are associated with lower crude death rates. Permit requirements, extreme risk protection orders, untraceable firearm restrictions, tracing, and trafficking policies are associated with lower crude suicide rates. Implementation of these policies nationwide may reduce crude death rates and crude suicide rates.
{"title":"Associations between state gun policies and firearm-related deaths in the United States: A mixed-effects analysis from 2003 to 2022","authors":"Melissa A. Kendall MD, Emily A. Grimsley MD, Rachel L. Wolansky MD, Joseph Sujka MD, Paul C. Kuo MD, MS, MBA","doi":"10.1016/j.surg.2025.109911","DOIUrl":"10.1016/j.surg.2025.109911","url":null,"abstract":"<div><h3>Background</h3><div>Firearm-related deaths are prevalent in the United States, with the second greatest total recorded in 2022. Data associating handgun policies with firearm-related crude death rates by all intentions and crude suicide rates remain inconclusive. We aimed to identify associations between handgun policies and crude death rates and crude suicide rates over time.</div></div><div><h3>Methods</h3><div>We queried the Centers for Disease Control and Prevention database for adult crude death rates and crude suicide rates in the United States and the Research and Development Firearm Database to identify state-specific handgun policies. We analyzed data from 2003 to 2022 using 2 mixed-effects models: crude death rates and crude suicide rates. Linear and quadratic interaction terms captured changes in policy effectiveness over time. Robust standard errors accounted for heteroscedasticity, improving estimate reliability.</div></div><div><h3>Results</h3><div>Safety training requirements reduced crude death rates by 29.0% (<em>P</em> < .01), followed by possession restrictions (12.2%; <em>P</em> < .01), registration requirements (8.9%; <em>P</em> < .05), and tracing requirements (6.1%; <em>P</em> < .05). Permit requirements reduced crude suicide rates by 15.9% (<em>P</em> < .05), followed by extreme risk protection orders (6.7%; <em>P</em> < .001), untraceable firearms restrictions 5.9%; <em>P</em> < .05), tracing requirements (4.3%; <em>P</em> < .05), and trafficking policies (4.2%; <em>P</em> < .05). Preemption of local policies increased crude suicide rates by 9.8% (<em>P</em> < .01). The effect of tracing requirements increased from 2003–2022 for both crude death rates (6.1% to 30.6%; <em>P</em> < .01) and crude suicide rates (4.3% to 22.5%; <em>P</em> < .05). The effect of preemption of select local policies initially weakened from 2003–2012, (+12.2% to +9.7%), then strengthened to +15.3% in 2022 (<em>P</em> < .01).</div></div><div><h3>Conclusion</h3><div>Safety training, possession requirements, handgun registration, and tracing policies are associated with lower crude death rates. Permit requirements, extreme risk protection orders, untraceable firearm restrictions, tracing, and trafficking policies are associated with lower crude suicide rates. Implementation of these policies nationwide may reduce crude death rates and crude suicide rates.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"191 ","pages":"Article 109911"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146019682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-12-06DOI: 10.1016/j.surg.2025.109909
Anna Levine DO , Hayden Wood BS , Ibukunoluwa Omole BA , Amie M. Hop MD , G. Paul Wright MD , Jessica L. Thompson MD
Background
Approximately 20% of women diagnosed with ductal carcinoma in situ on core biopsy will be upstaged to invasive disease on final pathology. Sentinel lymph node biopsy at the time of mastectomy for ductal carcinoma in situ is the current standard of care. However, the underlying invasive cancer is frequently of low grade with favorable biology, bringing into question the necessity of sentinel lymph node biopsy to help guide clinical treatment recommendations. The primary study objective was to determine how often sentinel lymph node biopsy at the time of mastectomy for ductal carcinoma in situ alters adjuvant therapy recommendations.
Methods
A single-institution cancer registry retrospectively identified women treated with mastectomy for a preoperative diagnosis of ductal carcinoma in situ between November 2017 and November 2023, excluding those with a previous history of ipsilateral breast cancer. The impact of pathologic nodal status on adjuvant treatment was evaluated.
Results
The study population included 175 patients with a total of 38 invasive cancers identified. Of those with pT1 malignancies, 3 had a positive sentinel node. One patient was recommended for additional adjuvant treatment, in the form of radiation therapy, as a result of axillary staging. No patients were recommended for chemotherapy based solely on sentinel lymph node biopsy results.
Conclusion
Despite current recommendations to perform sentinel lymph node biopsy in ductal carcinoma in situ treated with mastectomy in the event invasive cancer is identified on final pathology, our outcomes suggest nodal status has limited impact on adjuvant therapy offerings. These findings indicate that sentinel lymph node biopsy may not be requisite for every patient undergoing mastectomy for ductal carcinoma in situ.
{"title":"Axillary staging outcomes in women undergoing mastectomy for ductal carcinoma in situ in the era of gene expression assays","authors":"Anna Levine DO , Hayden Wood BS , Ibukunoluwa Omole BA , Amie M. Hop MD , G. Paul Wright MD , Jessica L. Thompson MD","doi":"10.1016/j.surg.2025.109909","DOIUrl":"10.1016/j.surg.2025.109909","url":null,"abstract":"<div><h3>Background</h3><div>Approximately 20% of women diagnosed with ductal carcinoma in situ on core biopsy will be upstaged to invasive disease on final pathology. Sentinel lymph node biopsy at the time of mastectomy for ductal carcinoma in situ is the current standard of care. However, the underlying invasive cancer is frequently of low grade with favorable biology, bringing into question the necessity of sentinel lymph node biopsy to help guide clinical treatment recommendations. The primary study objective was to determine how often sentinel lymph node biopsy at the time of mastectomy for ductal carcinoma in situ alters adjuvant therapy recommendations.</div></div><div><h3>Methods</h3><div>A single-institution cancer registry retrospectively identified women treated with mastectomy for a preoperative diagnosis of ductal carcinoma in situ between November 2017 and November 2023, excluding those with a previous history of ipsilateral breast cancer. The impact of pathologic nodal status on adjuvant treatment was evaluated.</div></div><div><h3>Results</h3><div>The study population included 175 patients with a total of 38 invasive cancers identified. Of those with pT1 malignancies, 3 had a positive sentinel node. One patient was recommended for additional adjuvant treatment, in the form of radiation therapy, as a result of axillary staging. No patients were recommended for chemotherapy based solely on sentinel lymph node biopsy results.</div></div><div><h3>Conclusion</h3><div>Despite current recommendations to perform sentinel lymph node biopsy in ductal carcinoma in situ treated with mastectomy in the event invasive cancer is identified on final pathology, our outcomes suggest nodal status has limited impact on adjuvant therapy offerings. These findings indicate that sentinel lymph node biopsy may not be requisite for every patient undergoing mastectomy for ductal carcinoma in situ.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"191 ","pages":"Article 109909"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145696314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}